BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 21652178)

  • 1. Brief cognitive assessment instruments in schizophrenia and bipolar patients, and healthy control subjects: a comparison study between the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS) and the Screen for Cognitive Impairment in Psychiatry (SCIP).
    Cuesta MJ; Pino O; Guilera G; Rojo JE; Gómez-Benito J; Purdon SE; Franco M; Martínez-Arán A; Segarra N; Tabarés-Seisdedos R; Vieta E; Bernardo M; Crespo-Facorro B; Mesa F; Rejas J
    Schizophr Res; 2011 Aug; 130(1-3):137-42. PubMed ID: 21652178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurocognitive diagnosis and cut-off scores of the Screen for Cognitive Impairment in Psychiatry (SCIP-S).
    Rojo E; Pino O; Guilera G; Gómez-Benito J; Purdon SE; Crespo-Facorro B; Cuesta MJ; Franco M; Martínez-Arán A; Segarra N; Tabarés-Seisdedos R; Vieta E; Bernardo M; Mesa F; Rejas J;
    Schizophr Res; 2010 Feb; 116(2-3):243-51. PubMed ID: 19744832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spanish version of the Screen for Cognitive Impairment in Psychiatry (SCIP-S): psychometric properties of a brief scale for cognitive evaluation in schizophrenia.
    Pino O; Guilera G; Rojo JE; Gómez-Benito J; Bernardo M; Crespo-Facorro B; Cuesta MJ; Franco M; Martinez-Aran A; Segarra N; Tabarés-Seisdedos R; Vieta E; Purdon SE; Díez T; Rejas J;
    Schizophr Res; 2008 Feb; 99(1-3):139-48. PubMed ID: 17959358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using the Brief Assessment of Cognition in Schizophrenia (BACS) to assess cognitive impairment in older patients with schizophrenia and bipolar disorder.
    Cholet J; Sauvaget A; Vanelle JM; Hommet C; Mondon K; Mamet JP; Camus V
    Bipolar Disord; 2014 May; 16(3):326-36. PubMed ID: 24383665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimising screening for cognitive dysfunction in bipolar disorder: Validation and evaluation of objective and subjective tools.
    Jensen JH; Støttrup MM; Nayberg E; Knorr U; Ullum H; Purdon SE; Kessing LV; Miskowiak KW
    J Affect Disord; 2015 Nov; 187():10-9. PubMed ID: 26301477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 10-minute measure of global cognition: Validation of the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS).
    Hurford IM; Ventura J; Marder SR; Reise SP; Bilder RM
    Schizophr Res; 2018 May; 195():327-333. PubMed ID: 28918221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, II: convergent/discriminant validity and diagnostic group comparisons.
    Hobart MP; Goldberg R; Bartko JJ; Gold JM
    Am J Psychiatry; 1999 Dec; 156(12):1951-7. PubMed ID: 10588410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical usefulness of the screen for cognitive impairment in psychiatry (SCIP-S) scale in patients with type I bipolar disorder.
    Guilera G; Pino O; Gómez-Benito J; Rojo JE; Vieta E; Tabarés-Seisdedos R; Segarra N; Martínez-Arán A; Franco M; Cuesta MJ; Crespo-Facorro B; Bernardo M; Purdon SE; Díez T; Rejas J;
    Health Qual Life Outcomes; 2009 Apr; 7():28. PubMed ID: 19338661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The screen for cognitive impairment in psychiatry: diagnostic-specific standardization in psychiatric ill patients.
    Gómez-Benito J; Guilera G; Pino Ó; Rojo E; Tabarés-Seisdedos R; Safont G; Martínez-Arán A; Franco M; Cuesta MJ; Crespo-Facorro B; Bernardo M; Vieta E; Purdon SE; Mesa F; Rejas J;
    BMC Psychiatry; 2013 May; 13():127. PubMed ID: 23648193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The assessment of chosen psychometric features of B-CATS test battery in schizophrenia - preliminary report].
    Jędrasik-Styła M; Ciołkiewicz A; Styła R; Pankowski D; Denisiuk M; Linke M; Jarema M; Wichniak A
    Psychiatr Pol; 2014; 48(6):1189-200. PubMed ID: 25717488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examination of the validity of the Brief Neurocognitive Assessment (BNA) for schizophrenia.
    Fervaha G; Hill C; Agid O; Takeuchi H; Foussias G; Siddiqui I; Kern RS; Remington G
    Schizophr Res; 2015 Aug; 166(1-3):304-9. PubMed ID: 26004693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating the association between neurocognition and psychosis in bipolar disorder: further evidence for the overlap with schizophrenia.
    Jabben N; Arts B; Krabbendam L; van Os J
    Bipolar Disord; 2009 Mar; 11(2):166-77. PubMed ID: 19267699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Executive deficits: a continuum schizophrenia-bipolar disorder or specific to schizophrenia?
    Ancín I; Cabranes JA; Santos JL; Sánchez-Morla E; Barabash A
    J Psychiatr Res; 2013 Nov; 47(11):1564-71. PubMed ID: 23907000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the CogState Schizophrenia Battery and the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Battery in assessing cognitive impairment in chronic schizophrenia.
    Pietrzak RH; Olver J; Norman T; Piskulic D; Maruff P; Snyder PJ
    J Clin Exp Neuropsychol; 2009 Oct; 31(7):848-59. PubMed ID: 19142774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological evidence for abnormal neurodevelopment associated with early-onset psychoses.
    Bombin I; Mayoral M; Castro-Fornieles J; Gonzalez-Pinto A; de la Serna E; Rapado-Castro M; Barbeito S; Parellada M; Baeza I; Graell M; Payá B; Arango C
    Psychol Med; 2013 Apr; 43(4):757-68. PubMed ID: 22831788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive deficits and its relation with psychopathology and global functioning in first episode schizophrenia.
    Hegde S; Thirthalli J; Rao SL; Raguram A; Philip M; Gangadhar BN
    Asian J Psychiatr; 2013 Dec; 6(6):537-43. PubMed ID: 24309868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Validation of the Cognitive Impairment in Psychiatry (SCIP-S) Screen Scale in Patients with Bipolar Disorder I].
    Castaño Ramírez OM; Martínez Ramírez YA; Marulanda Mejía F; Díaz Cabezas R; Valderrama Sánchez LA; Varela Cifuentes V; Aguirre Acevedo DC
    Rev Colomb Psiquiatr; 2015; 44(1):20-7. PubMed ID: 26578215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of neurocognitive function in euthymic bipolar patients and stabilized schizophrenic patients.
    Sánchez-Morla EM; Barabash A; Martínez-Vizcaíno V; Tabarés-Seisdedos R; Balanzá-Martínez V; Cabranes-Díaz JA; Baca-Baldomero E; Gómez JL
    Psychiatry Res; 2009 Oct; 169(3):220-8. PubMed ID: 19758705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An empirical evaluation of the MATRICS Consensus Cognitive Battery in bipolar disorder.
    Van Rheenen TE; Rossell SL
    Bipolar Disord; 2014 May; 16(3):318-25. PubMed ID: 24119238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.